A Policy Call to Address Rare Kidney Disease in Health Care Plans
Raymond Vanholder(Ghent University Hospital), Franz Schaefer(Heidelberg University), Willem Jan W. Bos(St. Antonius Ziekenhuis), Elaine Damato(Heidelberg University), Eveline Scheres(Heidelberg University), Michele Pistollato(Heidelberg University), Alberto Ortíz(Universidad Pontificia de Salamanca), Fádi Fakhouri(University Hospital of Lausanne), Rosanna Coppo(Fondazione Ricerca Molinette), Alister Humphreys(Heidelberg University), Ionuţ Nistor(Grigore T. Popa University of Medicine and Pharmacy)
Cited by 23
Related Papers
Non-Transgenic Mouse Models of Kidney Disease
|The Nephron journals/Nephron journals|2016|1.9k
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
|Journal of Hypertension|2016|1.4k
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
|Kidney International|2009|1.2k
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
|Kidney International|2009|1k